©The Author(s) 2025.
World J Gastrointest Pathophysiol. Dec 22, 2025; 16(4): 111029
Published online Dec 22, 2025. doi: 10.4291/wjgp.v16.i4.111029
Published online Dec 22, 2025. doi: 10.4291/wjgp.v16.i4.111029
Figure 3 Gut–liver–brain axis examining the association between metabolic dysfunction–associated steatotic liver disease and depre ssion/anxiety.
SCFA: Short-chain fatty acids; LPS: Lipopolysaccharides; BBB: Blood–brain barrier; BDNF: Brain-derived neurotrophic factor; GABA: Gamma-aminobutyric acid; MASLD: Metabolic dysfunction–associated steatotic liver disease.
- Citation: Sampada, Naseem M, Solanki M, Sharma R, Singh C, Sohal A. Pathophysiology of depression and anxiety in metabolic dysfunction-associated steatotic liver disease. World J Gastrointest Pathophysiol 2025; 16(4): 111029
- URL: https://www.wjgnet.com/2150-5330/full/v16/i4/111029.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v16.i4.111029